Abstract
Central endocannabinoid signaling is known to be responsive to stressful stimuli; however, there is no research to date characterizing the effects of stress on peripheral endocannabinoid content. The current study examined serum content of the endocannabinoid ligands N-arachidonylethanolamide (anandamide; AEA) and 2-arachidonoylglycerol (2-AG), and the non-cannabinoid N-acyl ethanolamine (NAE) molecules palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) under basal conditions, immediately following the Trier Social Stress Test (TSST), and 30 min thereafter, in 15 medication-free women diagnosed with major depression, and 15 healthy matched controls. Basal serum concentrations of AEA and 2-AG, but not PEA or OEA, were significantly reduced in women with major depression relative to matched controls, indicating a deficit in peripheral endocannabinoid activity. Immediately following the TSST, serum 2-AG concentrations were increased compared to baseline; serum AEA concentration was unchanged at this time point. Serum concentrations of PEA and OEA were significantly lower than baseline 30 min following the cessation of the TSST. The magnitude of these responses did not differ between depressed and control subjects. These are the first data to demonstrate that the peripheral endocannabinoid/NAE system is responsive to exposure to stress.
Original language | English (US) |
---|---|
Pages (from-to) | 1257-1262 |
Number of pages | 6 |
Journal | Psychoneuroendocrinology |
Volume | 34 |
Issue number | 8 |
DOIs | |
State | Published - Sep 2009 |
Funding
This research was supported by operating grants from the American Heart Association and the Canadian Institutes of Health Research (CIHR) to GEM; a Young Investigator Award from NARSAD and a Michael Smith Foundation for Health Research (MSFHR) Scholar Award to GEM; partial funding was provided by Research for a Healthier Tomorrow, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin (CJH); operating grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) and CIHR to BBG; and a MSFHR postgraduate trainee award and a NSERC Canadian Graduate Scholarship to MNH. None of these institutions had any further role in study design, collection, analysis or interpretation of the data nor in the decision to submit this paper for publication.
Keywords
- Antidepressant
- Cannabinoid
- Depression
- Metabolic
- Stress
- Sympathetic
ASJC Scopus subject areas
- Endocrine and Autonomic Systems
- Psychiatry and Mental health
- Biological Psychiatry
- Endocrinology
- Endocrinology, Diabetes and Metabolism